Principal Investigator/Program Director (Last, first, middle): Hansen, Laura, A RESEARCH &RELATED Other Project Information 1. * Are Human Subjects Involved? m Yes l No 1.a. If YES to Human Subjects Is the IRB review Pending? m Yes m No IRB Approval Date: Exemption Number: 1 2 3 4 5 6 Human Subject Assurance Number 2. * Are Vertebrate Animals Used? l Yes m No 2.a. If YES to Vertebrate Animals Is the IACUC review Pending? l Yes m No IACUC Approval Date: Animal Welfare Assurance Number A3348-01 3. * Is proprietary/privileged information m Yes l No included in the application? 4.a.* Does this project have an actual or potential impact on m Yes l No the environment? 4.b. If yes, please explain: 4.c. If this project has an actual or potential impact on the environment, has an exemption been authorized or an environmental assessment (EA) or environmental impact statement (EIS) been performed? m Yes m No 4.d. If yes, please explain: 5.a.* Does this project involve activities outside the U.S. or m Yes l No partnership with International Collaborators? 5.b. If yes, identify countries: 5.c. Optional Explanation: 6. * Project Summary/Abstract 7587-Project_summary-abstract.pdf Mime Type: application/pdf 7. * Project Narrative 1005-project_narrative.pdf Mime Type: application/pdf 8. Bibliography &References Cited 7032-Bib_and_ref_cited.pdf Mime Type: application/pdf 9. Facilities &Other Resources 4565-Facilities_and_other_resources.pdfMime Type: application/pdf 10. Equipment 4335-equipment.pdf Mime Type: application/pdf Tracking Number: Other Information Page 5 OMB Number: 4040-0001 Expiration Date: 04/30/2008 Principal Investigator/Program Director (Last, first, middle): Hansen, Laura, A Project Summary-Abstract Exposure to the ultraviolet (UV) component of sunlight is the major cause of nonmelanoma skin cancer, the most common form of cancer in the United States. Despite its significance for human health, however, the mechanisms through which UV causes cancer are not well understood. One potential mechanism for skin carcinogenesis involves the UV-induced activation of Erbb2, a proto-oncogene and orphan receptor tyrosine kinase. Our preliminary data reveal novel mechanisms through which Erbb2 contributes to skin carcinogenesis at multiple stages, both during tumor development and progression. Our central hypotheses are 1) that Erbb2 promotes cell cycle progression and thus increases UV-induced skin carcinogenesis by dampening DNA damage response checkpoints and 2) that Erbb2's suppression of proteinase inhibitor Thrombospondin 1 and its upregulation of matrix metalloproteinases stimulate keratinocyte invasion and angiogenesis, leading to malignant progression. The long-term objective of this application is to understand the biological functions of Erbb2 during carcinogenesis and the mechanisms through which Erbb2 acts. Studies are proposed to reveal the biological significance of Erbb2 in skin tumor development and progression, to determine the molecular mechanisms by which Erbb2 regulates cell cycle progression and a DNA damage checkpoint through Cdc25a, and to determine how Erbb2 causes skin cancer progression. These studies will use models that we have developed for both the inhibition and genetic ablation of Erbb2 in the skin. Upon completion, these studies will reveal the basic mechanisms of cell cycle regulation and checkpoint control following UV exposure as well as novel mechanisms through which Erbb2 regulates cell cycle arrest after DNA damage and promotes malignant progression. This research will provide a comprehensive analysis of the importance of Erbb2 in skin carcinogenesis, will elucidate novel mechanisms through which Erbb2 acts, and will provide new targets for therapeutic intervention during skin carcinogenesis. Project Description Page 6

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Research Project (R01)
Project #
Application #
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Humble, Michael C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Creighton University
Other Basic Sciences
Schools of Medicine
United States
Zip Code
Bichsel, Kyle J; Hammiller, Brianna; Trempus, Carol S et al. (2016) The epidermal growth factor receptor decreases Stathmin 1 and triggers catagen entry in the mouse. Exp Dermatol 25:275-81
Rao, Velidi H; Vogel, Kristen; Yanagida, Jodi K et al. (2015) Erbb2 up-regulation of ADAM12 expression accelerates skin cancer progression. Mol Carcinog 54:1026-36
Hammiller, Brianna O; El-Abaseri, Taghrid Bahig; Dlugosz, Andrzej A et al. (2015) A Method for the Immortalization of Newborn Mouse Skin Keratinocytes. Front Oncol 5:177
El-Abaseri, Taghrid Bahig; Hammiller, Brianna; Repertinger, Susan K et al. (2013) The epidermal growth factor receptor increases cytokine production and cutaneous inflammation in response to ultraviolet irradiation. ISRN Dermatol 2013:848705
Bichsel, Kyle J; Gogia, Navdeep; Malouff, Timothy et al. (2013) Role for the epidermal growth factor receptor in chemotherapy-induced alopecia. PLoS One 8:e69368
Rao, V H; Kandel, A; Lynch, D et al. (2012) A positive feedback loop between HER2 and ADAM12 in human head and neck cancer cells increases migration and invasion. Oncogene 31:2888-98
Yanagida, Jodi; Hammiller, Brianna; Al-Matouq, Jenan et al. (2012) Accelerated elimination of ultraviolet-induced DNA damage through apoptosis in CDC25A-deficient skin. Carcinogenesis 33:1754-61
Virador, Victoria M; Flores-Obando, Rafael E; Berry, Adam et al. (2009) The human promyelocytic leukemia protein is a tumor suppressor for murine skin carcinogenesis. Mol Carcinog 48:599-609
Madson, Justin G; Lynch, David T; Svoboda, Jessica et al. (2009) Erbb2 suppresses DNA damage-induced checkpoint activation and UV-induced mouse skin tumorigenesis. Am J Pathol 174:2357-66
Maklad, Adel; Nicolai, Jodi R; Bichsel, Kyle J et al. (2009) The EGFR is required for proper innervation to the skin. J Invest Dermatol 129:690-8